Increased and localized accumulation of chondroitin sulphate proteoglycans in the hyperplastic human prostate

BJU International

Volumn 93, Issue 4, 2004, Pages 532-538

  Cardoso, L E M ^a   Falcao P G ^a   Sampaio, F J B ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Adenoma; BPH; Chondroitin sulphate proteoglycans; Connective tissue; Prostate; Smooth muscle

Indexed keywords

ALPHA ACTIN; ANTIBODY; COLLAGEN TYPE 4; LAMININ; PERLECAN; PROSTATE SPECIFIC ANTIGEN; PROTEOCHONDROITIN SULFATE; CHONDROITIN SULFATE;

ADENOMA; ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; CELL PROLIFERATION; CLINICAL ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; CORRELATION FUNCTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCORING SYSTEM; STROMA; TISSUE SECTION; SMOOTH MUSCLE FIBER;

AGED; AGED, 80 AND OVER; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUSCLE, SMOOTH; PROSTATE; PROSTATIC HYPERPLASIA; PROTEOCHONDROITIN SULFATES;

EID: 1642392311     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2003.04688.x     Document Type: Article

References (37)

1. Jacobsen SJ, Girman G, Lieber MM. Natural history of benign prostatic hyperplasia. Urology 2001; 58 (Suppl. 6a): 5-16
2. Thompson TC, Yang G. Regulation of apoptosis in prostatic disease. Prostate 2000; 9: 25-8
3. Collins AT, Robinson EJ, Neal DE. Benign prostatic stromal cells are regulated by basic fibroblast growth factor and transforming growth factor beta-1. J Endocrinol 1996; 151: 315-22
4. Ittmann M, Mansukhani A. Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate. J Urol 1997; 157: 351-6
5. Luo J, Dunn T, Ewing C et al. Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis. Prostate 2002; 51: 189-200
6. Pullen M, Thomas K, Wu H, Nambi P. Stimulation of hyaluronan synthetase by platelet-derived growth factor β in human prostate smooth muscle cells. Pharmacology 2001; 62: 103-6
7. Iozzo RV. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998; 67: 609-52
8. Aydin O, Dusmez D, Cinel L, Doruk E, Kanik A. Immunohistological analysis of mast cell numbers in the intratumoral and peritumoral regions of prostate carcinoma compared to benign prostatic hyperplasia. Pathol Res Pract 2002; 198: 267-71
9. Cohen RJ, Holland JW, Redmond SL, McNeal JE, Dawkins HJ. Identification of the glycosaminoglycan keratan sulfate in the prostatic secretory cell. Prostate 2000; 44: 204-9
10. Schamhart DH, Kurth KH. Role of proteoglycans in cell adhesion of prostate cancer cells: from review to experiment. Urol Res 1997; 25: 589-596
11. Glynne-Jones E, Harper ME, Seery LT et al. TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence. Int J Cancer 2001; 94: 178-84
12. De Klerk DP. The glycosaminoglycans of normal and hyperplastic prostate. Prostate 1983; 4: 73-81
13. Iida S, Suzuki K, Matsuoka K et al. Analysis of glycosaminoglycans in human prostate by high-performance liquid chromatography. Br J Urol 1997; 79: 763-9
14. Goulas A, Hatzichristou DG, Karakiulakis G, Mirtsou-Fidani V, Kalinderis A, Papakonstantinou E. Benign hyperplasia of the human prostate is associated with tissue enrichment in chondroitin sulphate of wide size distribution. Prostate 2000; 44: 104-10
15. McNeal JE. Anatomy of the prostate and morphogenesis of BPH. Prog Clin Biol Res 1984; 145: 27-53
16. Srodon M, Epstein JI. Central zone histology of the prostate: a mimicker of high-grade prostatic intraepithelial neoplasia. Hum Pathol 2002; 33: 518-23
17. Terry DE, Clark AF. Glycosaminoglycans in the three lobes of the rat prostate following castration and testosterone treatment. Biochem Cell Biol 1996; 74: 653-8
18. Li SC, Chen GF, Chan PS, Choi HL, Ho SM, Chan FL. Altered expression of extracellular matrix and proteinases in Noble rat prostate gland after long-term treatment with sex steroids. Prostate 2001; 49: 58-71
19. Pinheiro AC, Costa WS, Cardoso LE, Sampaio FJ. Organization and relative content of smooth muscle cells, collagen, and elastic fibers in the corpus cavernosum of the rat penis. J Urol 2000; 164: 1802-6
20. Sokal RR, Rohlf FJ. Biometry, 3rd edn. New York: WH Freeman, 1995: 887
21. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001; 164: S28-S38
22. Meleg-Smith S. Alport disease, a review of the diagnostic difficulties. Ultrastruct Pathol 2001; 25: 193-200
23. Ulrich P, Cerami A. Protein glycation, diabetes, and aging. Recent Prog Horm Res 2001; 56: 1-21
24. Kalaria RN. Cerebral vessels in ageing and Alzheimer's disease. Pharmacol Ther 1996; 72: 193-214
25. Thyberg J, Palmberg L, Nilsson J, Ksiazek T, Sjolund M. Phenotvpe modulation in primary cultures of arterial smooth muscle cells. On the role of platelet-derived growth factor. Differentiation 1983; 25: 156-67
26. Horsfall DJ, Mayne K, Skinner JM, Saccone GT, Marshall VR, Tilley WD. Glycosaminoglycans of guinea pig prostate fibromuscular stroma: influence of estrogen and androgen on levels and location of chondroitin sulfate. Prostate 1994; 25: 320-32
27. Schonherr E, Jarvelainen HT, Sandell LJ, Wight TN. Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem 1991; 266: 17640-7
28. Schonherr E, Kinsella MG, Wight TN. Genistein selectively inhibits platelet-derived growth factor-stimulated versican biosynthesis in monkey arterial smooth muscle cells. Arch Biochem Biophys 1997; 339: 353-61
29. Dours-Zimmermann MT, Zimmermann DR. A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican. J Biol Chem 1994; 269: 32992-8
30. Couchman JR, Kapoor R, Sthanam M, Wu RR. Perlecan and basement membrane-chondroitin sulfate proteoglycan (bamacan) are two basement membrane chondroitin/ dermatan sulfate proteoglycans in the Engelbreth-Holm-Swarm tumor matrix. J Biol Chem 1996; 271: 9595-602
31. Ghiselli G, Siracusa LD, Iozzo RV. Complete cDNA cloning, genomic organization, chromosomal assignment, functional characterization of the promoter, and expression of the murine bamacan gene. J Dial Chem 1999; 274: 17384-93
32. Ghiselli G, Iozzo RV. Overexpression of bamacan/SMC3 causes transformation. J Biol Chem 2000; 275: 20235-8
33. Ljubimov AV, Burgeson RE, Butkowski RJ et al. Basement membrane abnormalities in human eyes with diabetic retinopathy. J Histochem Cytochem 1996; 44: 1469-79
34. Ljubimov AV, Burgeson RE, Butkowski RJ et al. Extracellular matrix alterations in human corneas with bullous keratopathy. Invest Ophthalmol Vis Sci 1996; 37: 997-1007
35. Worapamorn W, Haase HR, Li H, Bartold PM. Growth factors and cytokines modulate gene expression of cell-surface proteoglycans in human periodontal ligament cells. J Cell Physiol 2001; 186: 448-56
36. Doll JA, Reiher FK, Crawford SE, Pins MR, Campbell SC, Bouck NP. Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate. Prostate 2001; 49: 293-305
37. Handisurya A, Steiner GE, Stix U et al. Differential expression of interleukin-15, a pro-inflammatory cytokine and T-cell growth factor, and its receptor in human prostate. Prostate 2001; 49: 251-62